EQ

Equillium, Inc.

Healthcare · Biotechnology

$143.41 sample

-0.73 (-0.51%) 1D

Market cap

$497.8B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-06

Alerts

8

Price$143.41 +8.93% 3M daily closessample

144.98128.97

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06SEC8-K filed: material event
Oct 01INSInsider sell: Director
Sep 23INSInsider sell: 10% owner
Sep 17INSInsider sell: Chief Executive Officer
Sep 09INSInsider sell: Director
Sep 02INSInsider sell: General Counsel
Aug 26INSInsider sell: 10% owner
Aug 18SECForm 144 filed

Sign up to see the real EQ record →

Company facts

SEC EDGAR registration

Name: Equillium, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -37sample, -100 to +100
Reporting currency: USD

Who is positioning in EQ

sample

Insiders: 30 insider transactions over 90 days, net selling, $777.7M
Congress: No member trades over 90 days
Institutions · 13F: 23 funds hold $6.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$29.4B +14.4% y/y

Q4 2024Q3 2026

Inventory$17.3B +8.8% y/y

Q4 2024Q3 2026

Accounts receivable$13.8B +12.0% y/y

Q4 2024Q3 2026

Total debt$36.4B +20.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $335.9B -11.7% 3M
Sample peer B: $170.8B -4.2% 3M
Sample peer C: $284.9B +3.2% 3M
Sample peer D: $409.1B -11.3% 3M
Sample peer E: $256.6B -8.7% 3M